Clinical Trial Update: Study of TRAVATAN in Subjects With Iris Pigmentation Changes

View source ↗

Summary

This clinical trial update reports termination of a study evaluating TRAVATAN (travoprost) in subjects with open-angle glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travatan (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Status: TERMINATED